Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh · Delayed Price · Currency is BDT

89.20

+0.50 (0.56%)

At close: Nov 4, 2026

Market Cap	20.61B -18.2%
Revenue (ttm)	16.43B +30.2%
Net Income	1.94B +74.1%
EPS	8.41 +74.1%
Shares Out	231.00M
PE Ratio	10.61
Forward PE	n/a
Dividend	2.10 (2.35%)
Ex-Dividend Date	Nov 11, 2026

Volume	54,957
Open	n/a
Previous Close	88.70
Day's Range	88.50 - 90.50
52-Week Range	87.60 - 117.90
Beta	-0.02
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 5, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestin... [Read more]

Industry Pharmaceutical Preparations

Founded 2001

Employees 4,771

Stock Exchange Dhaka Stock Exchange

Ticker Symbol BEACONPHAR

Full Company Profile

Financial Performance

In fiscal year 2025, Beacon Pharmaceuticals's revenue was 12.54 billion, an increase of 17.20% compared to the previous year's 10.70 billion. Earnings were 946.51 million, an increase of 81.67%.

Financial Statements